Latest Insider Transactions at Kiniksa Pharmaceuticals, Ltd. (KNSA)
This section provides a real-time view of insider transactions for Kiniksa Pharmaceuticals, Ltd. (KNSA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Kiniksa Pharmaceuticals, Ltd. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Kiniksa Pharmaceuticals, Ltd.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 26
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
200
-0.87%
|
$8,400
$42.89 P/Share
|
|
Nov 26
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
200
+0.87%
|
$4,400
$22.89 P/Share
|
|
Nov 17
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
12,470
-18.03%
|
$498,800
$40.69 P/Share
|
|
Nov 17
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+15.59%
|
$52,000
$8.83 P/Share
|
|
Nov 13
2025
|
Sanj K Patel CHAIRMAN & CEO |
BUY
Bona fide gift
|
Indirect |
60,000
+50.0%
|
-
|
|
Nov 13
2025
|
Sanj K Patel CHAIRMAN & CEO |
SELL
Bona fide gift
|
Indirect |
60,000
-53.67%
|
-
|
|
Nov 12
2025
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
19,900
-39.03%
|
$796,000
$40.94 P/Share
|
|
Nov 12
2025
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
19,900
+28.07%
|
$597,000
$30.93 P/Share
|
|
Nov 12
2025
|
Sanj K Patel CHAIRMAN & CEO |
BUY
Bona fide gift
|
Indirect |
111,794
+50.0%
|
-
|
|
Nov 12
2025
|
Sanj K Patel CHAIRMAN & CEO |
SELL
Bona fide gift
|
Direct |
111,794
-100.0%
|
-
|
|
Oct 31
2025
|
John F. Paolini CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
82,542
-57.37%
|
$3,054,054
$37.14 P/Share
|
|
Oct 31
2025
|
John F. Paolini CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
82,542
+25.71%
|
$495,252
$6.32 P/Share
|
|
Oct 28
2025
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
100
-0.32%
|
$4,100
$41.0 P/Share
|
|
Oct 28
2025
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
100
+0.32%
|
$3,000
$30.93 P/Share
|
|
Oct 22
2025
|
Sanj K Patel CHAIRMAN & CEO |
SELL
Open market or private sale
|
Direct |
97,390
-46.56%
|
$3,700,820
$38.83 P/Share
|
|
Oct 22
2025
|
Sanj K Patel CHAIRMAN & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
97,390
+31.77%
|
$292,170
$3.8 P/Share
|
|
Oct 21
2025
|
Sanj K Patel CHAIRMAN & CEO |
SELL
Open market or private sale
|
Direct |
39,331
-26.03%
|
$1,494,578
$38.77 P/Share
|
|
Oct 21
2025
|
Sanj K Patel CHAIRMAN & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
39,331
+20.65%
|
$117,993
$3.8 P/Share
|
|
Oct 20
2025
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
50,490
-40.45%
|
$1,969,110
$39.02 P/Share
|
|
Oct 20
2025
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
39,435
+11.32%
|
$473,220
$12.46 P/Share
|
|
Oct 20
2025
|
Sanj K Patel CHAIRMAN & CEO |
SELL
Open market or private sale
|
Direct |
121,248
-29.55%
|
$4,728,672
$39.07 P/Share
|
|
Oct 20
2025
|
Sanj K Patel CHAIRMAN & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
121,248
+34.22%
|
$363,744
$3.8 P/Share
|
|
Oct 14
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
12,368
-15.34%
|
$457,616
$37.82 P/Share
|
|
Oct 14
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+13.67%
|
$52,000
$8.83 P/Share
|
|
Oct 04
2025
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
85
-0.22%
|
$3,230
$38.49 P/Share
|
|
Oct 04
2025
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
175
+0.46%
|
-
|
|
Sep 29
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
42,000
-54.86%
|
$1,596,000
$38.33 P/Share
|
|
Sep 29
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
42,000
+35.43%
|
$714,000
$17.92 P/Share
|
|
Sep 15
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
16,400
-16.25%
|
$590,400
$36.73 P/Share
|
|
Sep 15
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+11.31%
|
$52,000
$8.83 P/Share
|
|
Sep 05
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
13,389
-23.15%
|
$468,615
$35.66 P/Share
|
|
Sep 05
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
13,389
+18.8%
|
$200,835
$15.52 P/Share
|
|
Sep 04
2025
|
Ross Moat CHIEF CORP. & COMM. OFFICER |
SELL
Open market or private sale
|
Direct |
3,523
-27.23%
|
$123,305
$35.31 P/Share
|
|
Sep 04
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
85,271
-65.73%
|
$2,984,485
$35.52 P/Share
|
|
Sep 04
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
85,271
+29.09%
|
$1,279,065
$15.51 P/Share
|
|
Sep 03
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
15,091
-25.34%
|
$528,185
$35.5 P/Share
|
|
Sep 03
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
15,091
+10.15%
|
$226,365
$15.51 P/Share
|
|
Sep 03
2025
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
11,000
-22.44%
|
$374,000
$34.84 P/Share
|
|
Sep 03
2025
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+18.33%
|
$187,000
$17.92 P/Share
|
|
Sep 02
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
950
-2.09%
|
$32,300
$34.28 P/Share
|
|
Sep 02
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,964
+4.15%
|
-
|
|
Sep 02
2025
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
375
-0.98%
|
$12,750
$34.28 P/Share
|
|
Sep 02
2025
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
774
+1.98%
|
-
|
|
Sep 02
2025
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
900
-2.81%
|
$30,600
$34.28 P/Share
|
|
Sep 02
2025
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,861
+5.5%
|
-
|
|
Sep 02
2025
|
John F. Paolini CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
835
-1.34%
|
$28,390
$34.28 P/Share
|
|
Sep 02
2025
|
John F. Paolini CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,725
+2.7%
|
-
|
|
Sep 02
2025
|
Ross Moat CHIEF CORP. & COMM. OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
481
-3.58%
|
$16,354
$34.28 P/Share
|
|
Sep 02
2025
|
Ross Moat CHIEF CORP. & COMM. OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
994
+6.9%
|
-
|
|
Sep 02
2025
|
Sanj K Patel CHAIRMAN & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,177
-2.76%
|
$108,018
$34.28 P/Share
|